J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (122)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, L.
Right arrow Articles by Chow, M. S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, L.
Right arrow Articles by Chow, M. S. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

THERAPEUTIC REVIEWS/HERBAL MEDICINE

Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use

Limin Zhou, MSc, Zhong Zuo, PhD and Moses Sing Sum Chow, PharmD

From the School of Pharmacy and Drug Development Centre, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR, PRC.

Danshen, the dried root of Salvia miltiorrhiza, has been widely used in China and, to a lesser extent, in Japan, the United States, and other European countries for the treatment of cardiovascular and cerebrovascular diseases. In China, the specific clinical use is angina pectoris, hyperlipidemia, and acute ischemic stroke. The current review covers its traditional uses, chemical constituents, pharmacological activities, pharmacokinetics, clinical applications, and potential herb-drug interactions based on information obtained in both the English and Chinese literature. Although numerous clinical trials have demonstrated that certain Danshen products in China are effective and safe for the treatment of cardiovascular diseases, most of these lack sufficient quality. Therefore, large randomized clinical trials and further scientific research to determine its mechanism of actions will be necessary to ensure the safety, effectiveness, and better understanding of its action.


Key Words: Danshen • Salvia miltiorrhiza • danshensusalvianolic acid Btanshinone IIA

Address for reprints: Zhong Zuo, School of Pharmacy, Chinese University of Hong Kong, Shatin, N.T. Hong Kong; e-mail: joanzuo{at}cuhk.edu.hk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Liu, J. Morton, M. Miedzyblocki, T. F. Lee, D. L. Bigam, T. F. Fok, C. Chen, S. K. Lee, S. T. Davidge, and P.-Y. Cheung
Sodium tanshinone IIA sulfonate increased intestinal hemodynamics without systemic circulatory changes in healthy newborn piglets
Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1217 - H1224.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D.-S. Shin, H.-N. Kim, K. D. Shin, Y. J. Yoon, S.-J. Kim, D. C. Han, and B.-M. Kwon
Cryptotanshinone Inhibits Constitutive Signal Transducer and Activator of Transcription 3 Function through Blocking the Dimerization in DU145 Prostate Cancer Cells
Cancer Res., January 1, 2009; 69(1): 193 - 202.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
I. T. Nizamutdinova, G. W. Lee, J. S. Lee, M. K. Cho, K. H. Son, S. J. Jeon, S. S. Kang, Y. S. Kim, J. H. Lee, H. G. Seo, et al.
Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules
Carcinogenesis, October 1, 2008; 29(10): 1885 - 1892.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
F. Wieser, M. Cohen, A. Gaeddert, J. Yu, C. Burks-Wicks, S. L. Berga, and R. N. Taylor
Evolution of medical treatment for endometriosis: back to the roots?
Hum. Reprod. Update, September 1, 2007; 13(5): 487 - 499.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. J. Kim, S.-N. Jung, K. H. Son, S. R. Kim, T. Y. Ha, M. G. Park, I. G. Jo, J. G. Park, W. Choe, S.-S. Kim, et al.
Antidiabetes and Antiobesity Effect of Cryptotanshinone via Activation of AMP-Activated Protein Kinase
Mol. Pharmacol., July 1, 2007; 72(1): 62 - 72.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. D. Kim, F. A. Sanchez, R. G. Duran, T. Kanetaka, and W. N. Duran
Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2131 - H2137.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Clinical Pharmacology